FDA: More issues reported with drugs from Massachusetts facility
The FDA reports more problems with drugs from a Massachusetts compounding pharmacy, linked to a deadly outbreak of fungal meningitis.
The FDA reports more problems with drugs from a Massachusetts compounding pharmacy, linked to a deadly outbreak of fungal meningitis.